The quest for reliable seizure monitoring outside clinical settings has reached a pivotal moment, as wearable technologies now rival traditional brain monitoring for detecting life-threatening epileptic episodes. This breakthrough matters for the 65 million people worldwide with epilepsy, particularly those at risk of sudden unexpected death during generalized tonic-clonic seizures.
A comprehensive analysis of 29 studies reveals that combining electrodermal activity sensors with motion detectors and muscle activity monitors achieves 98.6% precision in seizure detection. The most effective combinations pair skin conductance sensors with accelerometers and gyroscopes, reaching 97.2% sensitivity with only 0.53 false alarms per day. For seizure prediction—the holy grail of epilepsy management—integrating skin conductance, blood volume pulse, motion sensors, and temperature monitoring achieved 75.6% sensitivity in forecasting episodes before they occur.
These findings represent a fundamental shift from brain-wave monitoring toward body-based detection systems. Unlike bulky EEG equipment requiring clinical expertise, these wearable sensors operate continuously in daily life while maintaining social acceptability. The technology addresses a critical gap in epilepsy care, where traditional monitoring fails during sleep or normal activities when many fatal seizures occur. However, significant validation hurdles remain before clinical deployment. Current studies involve relatively small patient cohorts, and the technology requires extensive personalization for individual seizure patterns. Privacy concerns and regulatory frameworks also need resolution before these promising devices can transform epilepsy management from reactive treatment to proactive prevention.